FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319826087> ?p ?o ?g. }

• W4319826087 endingPage "522" @default.
• W4319826087 startingPage "515" @default.
• W4319826087 abstract "Minimizing multiple organ dysfunction-related mortality and morbidity is a critical issue for patients with hypoxic-ischemic encephalopathy (HIE) receiving therapeutic hypothermia (TH). Although erythropoietin (EPO) has demonstrated protective effects on various hypoxic-ischemic organs in animal studies and clinical trials in adults, its effects on neonates with HIE require further investigation.This study retrospectively analyzed the medical records of neonates with HIE who received TH with or without EPO (TH+EPO vs TH groups) administration in a tertiary referral hospital from January 2016 to January 2021. Data regarding patient characteristics, medical treatment, and clinical (neurological, cardiac, respiratory, gastrointestinal, hepatic, and renal) function assessments were collected. To control for confounding factors and selection bias between the two groups, a 1:1 propensity matching method was applied.A total of 45 neonates with HIE received TH during the study period, with 24 patients (53%) in the TH+EPO group. After matching, each group enrolled 13 cases. No significant difference in mortality or hospital stay between the two groups was noted. During the first 3 days, the patients in the TH+EPO group showed significantly higher blood pressure (BP) than those in the TH group ( p < 0.05 on day 1). The TH+EPO group showed trends of higher blood hemoglobin ( p > 0.05) and creatinine ( p > 0.05) levels and lower estimated glomerular filtration rate ( p > 0.05) and urine output ( p > 0.05) during the first 2 weeks than TH group.The use of EPO in addition to TH is safe for neonates with HIE. The neonates with moderate or severe HIE who received EPO may have a lesser risk of hypotension than those who received TH alone. Further clinical studies on renal and cardiac functions and long-term neurological effects of EPO are required." @default.
• W4319826087 created "2023-02-11" @default.
• W4319826087 creator A5020194366 @default.
• W4319826087 creator A5037756064 @default.
• W4319826087 creator A5051368331 @default.
• W4319826087 creator A5067052370 @default.
• W4319826087 creator A5070898336 @default.
• W4319826087 date "2023-02-10" @default.
• W4319826087 modified "2023-09-30" @default.
• W4319826087 title "Effects of erythropoietin in neonates with hypoxic–ischemic encephalopathy receiving therapeutic hypothermia" @default.
• W4319826087 cites W186785599 @default.
• W4319826087 cites W1992659712 @default.
• W4319826087 cites W2013912494 @default.
• W4319826087 cites W2033671573 @default.
• W4319826087 cites W2046787333 @default.
• W4319826087 cites W2055343900 @default.
• W4319826087 cites W2065150571 @default.
• W4319826087 cites W2104070425 @default.
• W4319826087 cites W2321863348 @default.
• W4319826087 cites W2406821662 @default.
• W4319826087 cites W2576460726 @default.
• W4319826087 cites W2805484729 @default.
• W4319826087 cites W2888363878 @default.
• W4319826087 cites W2942503694 @default.
• W4319826087 cites W3008453445 @default.
• W4319826087 cites W3025600875 @default.
• W4319826087 cites W3124475668 @default.
• W4319826087 cites W3202890456 @default.
• W4319826087 cites W3212831614 @default.
• W4319826087 doi "https://doi.org/10.1097/jcma.0000000000000898" @default.
• W4319826087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36762934" @default.
• W4319826087 hasPublicationYear "2023" @default.
• W4319826087 type Work @default.
• W4319826087 citedByCount "0" @default.
• W4319826087 crossrefType "journal-article" @default.
• W4319826087 hasAuthorship W4319826087A5020194366 @default.
• W4319826087 hasAuthorship W4319826087A5037756064 @default.
• W4319826087 hasAuthorship W4319826087A5051368331 @default.
• W4319826087 hasAuthorship W4319826087A5067052370 @default.
• W4319826087 hasAuthorship W4319826087A5070898336 @default.
• W4319826087 hasBestOaLocation W43198260871 @default.
• W4319826087 hasConcept C126322002 @default.
• W4319826087 hasConcept C159641895 @default.
• W4319826087 hasConcept C2777390192 @default.
• W4319826087 hasConcept C2778534260 @default.
• W4319826087 hasConcept C2778621155 @default.
• W4319826087 hasConcept C2780306776 @default.
• W4319826087 hasConcept C2909832856 @default.
• W4319826087 hasConcept C42219234 @default.
• W4319826087 hasConcept C71924100 @default.
• W4319826087 hasConceptScore W4319826087C126322002 @default.
• W4319826087 hasConceptScore W4319826087C159641895 @default.
• W4319826087 hasConceptScore W4319826087C2777390192 @default.
• W4319826087 hasConceptScore W4319826087C2778534260 @default.
• W4319826087 hasConceptScore W4319826087C2778621155 @default.
• W4319826087 hasConceptScore W4319826087C2780306776 @default.
• W4319826087 hasConceptScore W4319826087C2909832856 @default.
• W4319826087 hasConceptScore W4319826087C42219234 @default.
• W4319826087 hasConceptScore W4319826087C71924100 @default.
• W4319826087 hasIssue "5" @default.
• W4319826087 hasLocation W43198260871 @default.
• W4319826087 hasLocation W43198260872 @default.
• W4319826087 hasLocation W43198260873 @default.
• W4319826087 hasOpenAccess W4319826087 @default.
• W4319826087 hasPrimaryLocation W43198260871 @default.
• W4319826087 hasRelatedWork W2000060824 @default.
• W4319826087 hasRelatedWork W2007451860 @default.
• W4319826087 hasRelatedWork W2058023068 @default.
• W4319826087 hasRelatedWork W2062479572 @default.
• W4319826087 hasRelatedWork W2765518338 @default.
• W4319826087 hasRelatedWork W2888248722 @default.
• W4319826087 hasRelatedWork W3008453445 @default.
• W4319826087 hasRelatedWork W4285386061 @default.
• W4319826087 hasRelatedWork W4310955238 @default.
• W4319826087 hasRelatedWork W4313643638 @default.
• W4319826087 hasVolume "86" @default.
• W4319826087 isParatext "false" @default.
• W4319826087 isRetracted "false" @default.
• W4319826087 workType "article" @default.